Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3.

MLA

McHugh, Daniel R., et al. “Linaclotide Improves Gastrointestinal Transit in Cystic Fibrosis Mice by Inhibiting Sodium/Hydrogen Exchanger 3.” American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 315, no. 5, Nov. 2018, pp. G868–78. EBSCOhost, https://doi.org/10.1152/ajpgi.00261.2017.

APA

McHugh, D. R., Cotton, C. U., Moss, F. J., Vitko, M., Valerio, D. M., Kelley, T. J., Hao, S., Jafri, A., Drumm, M. L., Boron, W. F., Stern, R. C., McBennett, K., & Hodges, C. A. (2018). Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium/hydrogen exchanger 3. American Journal of Physiology. Gastrointestinal and Liver Physiology, 315(5), G868–G878. https://doi.org/10.1152/ajpgi.00261.2017

Chicago

McHugh, Daniel R, Calvin U Cotton, Fraser J Moss, Megan Vitko, Dana M Valerio, Thomas J Kelley, Shuyu Hao, et al. 2018. “Linaclotide Improves Gastrointestinal Transit in Cystic Fibrosis Mice by Inhibiting Sodium/Hydrogen Exchanger 3.” American Journal of Physiology. Gastrointestinal and Liver Physiology 315 (5): G868–78. doi:10.1152/ajpgi.00261.2017.